Want to see CIRX full AI Analyst Report?
Top Page
Cirtran
(OTC:CIRX)
Select Model
Select Model
Rating:53Neutral
Price Target:
$0.04
▲(7.50% Upside)
Action:Reiterated
Date:08/19/26
The score is held back primarily by weak financial performance, driven by deeply negative equity and ongoing negative operating/free cash flow despite improving revenue growth and solid gross margins. Technical indicators are supportive with price above key moving averages and positive MACD/RSI momentum, while valuation appears low on P/E, partially offsetting the fundamental risks.
Positive Factors
Revenue Growth
Accelerating TTM revenue indicates improving demand or distribution activity and provides a stronger base for operating leverage. Sustained growth could help the company absorb fixed costs and improve profitability if execution remains consistent.
Negative Factors
Deeply Negative Equity
Deeply negative equity signals a materially impaired capital structure and restricts financial flexibility. It can make refinancing, raising capital, or supporting future investment more difficult, while increasing solvency risk even after the recent decline in debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Accelerating TTM revenue indicates improving demand or distribution activity and provides a stronger base for operating leverage. Sustained growth could help the company absorb fixed costs and improve profitability if execution remains consistent.
Read all positive factors
Cirtran (CIRX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$187.93K
Dividend YieldN/A
Average Volume (3M)12.02K
Price to Earnings (P/E)<0.1
Beta (1Y)-1.03
Revenue Growth336.70%
EPS GrowthN/A
CountryUS
Employees4
SectorIndustrials
Sector Strength72
IndustryFood Distribution
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,945,417
10 Day Avg. Volume9,745
30 Day Avg. Volume12,017
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.07
P/FCF Ratio-0.16
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cirtran Business Overview & Revenue Model
Company Description
CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company manufactures, distributes, and sells condoms, ele...
How the Company Makes Money
null...
Cirtran Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.83M | 3.13M | 1.30M | 1.62M | 1.72M | 2.92M |
| Gross Profit | 2.27M | 1.54M | 838.64K | 1.01M | 1.02M | 1.90M |
| EBITDA | 414.47K | 276.37K | -1.75M | 221.70K | -562.15K | -126.73K |
| Net Income | 2.13M | -701.63K | -2.63M | 20.29M | -1.35M | -627.38K |
Balance Sheet | ||||||
| Total Assets | 2.60M | 2.51M | 1.53M | 1.85M | 2.00M | 1.46M |
| Cash, Cash Equivalents and Short-Term Investments | 158.14K | 9.59K | 30.38K | 0.00 | 18.08K | 5.47K |
| Total Debt | 157.40K | 3.43M | 3.36M | 3.22M | 3.16M | 3.22M |
| Total Liabilities | 25.60M | 27.62M | 25.94M | 23.63M | 44.07M | 42.03M |
| Stockholders Equity | -22.99M | -25.11M | -24.41M | -21.78M | -42.07M | -40.56M |
Cash Flow | ||||||
| Free Cash Flow | -586.50K | -1.34M | -46.35K | -81.02K | 159.30K | 340.66K |
| Operating Cash Flow | -586.50K | -1.34M | -46.35K | -72.61K | 159.30K | 344.46K |
| Investing Cash Flow | 0.00 | 0.00 | 15.40K | -8.41K | 0.00 | -3.80K |
| Financing Cash Flow | 740.30K | 1.35M | 30.95K | 62.94K | -146.69K | -443.33K |
Cirtran Risk Analysis
Cirtran disclosed 16 risk factors in its most recent earnings report. Cirtran reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Cirtran Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $298.65M | 18.12 | 37.92% | ― | 11.24% | 31.12% | |
66 Neutral | $152.56M | 212.16 | 0.28% | ― | -57.96% | 75.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $291.51M | -3.64 | -27.83% | ― | 5.09% | 14.61% | |
55 Neutral | $866.72M | -5.50 | -21.01% | 2.49% | 8.37% | 51.01% | |
53 Neutral | $187.93K | 0.09 | ― | ― | 336.70% | ― | |
53 Neutral | $437.21M | 70.07 | 1.27% | ― | 25.45% | ― |
* Industrials Sector Average
CIRX
Cirtran
0.04
0.02
171.43%
CODI
Compass Diversified Holdings
11.25
4.06
56.47%
NNBR
NN
3.57
1.11
45.12%
RCMT
Rcm Technologies
40.97
13.75
50.51%
TRC
Tejon Ranch Company
16.14
-1.34
-7.67%
TUSK
Mammoth Energy Services
3.15
0.81
34.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.